カンザス州における大腸癌の臨床試験
カンザス州内の拠点で、大腸癌に関する19件の研究が参加者を募集しています。
カンザス州内の都市
公式研究テキスト（英語）
Family Communications After Genetic Testing
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
- 他1件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- 他4件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05803382A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Cancer Center of Kansas, Wichita
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Westwood
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06218914A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Cancer Center of Kansas, Wichita
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- University of Kansas, Fairway
被験者募集中第1相
12歳〜120歳 · 全性別 · 2026/09/23更新 · NCT04222413Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- The University of Kansas Clinical Research Center, Westwood
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06696768Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Westwood
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Kansas Cancer Center, Kansas City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- 他2件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT05691491Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Cancer Centers of Kansas, Wichita
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06937177Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Kansas, Kansas City
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- The University of Kansas Clinical Research Center, Fairway
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/01更新 · NCT06607458Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
被験者募集中第3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/03/31更新 · NCT07018869A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- The University of Kansas Cancer Center, Fairway
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/18更新 · NCT06244771Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- 他6件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204A Study of IBI363 in Subjects with Advanced Solid Malignancies
- University of Kansas Medical Center (KUMC), Fairway
被験者募集中第2相
18歳以上 · 全性別 · 2024/12/19更新 · NCT06281678ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。